MICHELLE SMITH: Open Payments
NPI 1194477588 · COLUMBUS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$186 in 11 payments from 8 companies in 2025. Trend: 2023 $460 · 2024 $179 · 2025 $186
Food & beverage: $186
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $64 |
| Novo Nordisk Inc | 2 | $32 |
| Lilly USA, LLC | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| PFIZER INC. | 1 | $14 |
| Organon LLC | 1 | $10 |
Products named: QULIPTA, VRAYLAR, ZEPBOUND, Wegovy, TRELEGY ELLIPTA, The Cologuard Plus Collection Kit, Rybelsus, PREVNAR 20.
Industry payments across IN — which companies pay providers there.
